IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,248,565 | +124.1% | 285,932 | +38.6% | 0.01% | +120.0% |
Q1 2023 | $5,020,155 | -71.2% | 206,336 | -74.6% | 0.01% | -73.7% |
Q4 2022 | $17,405,623 | +1020.8% | 812,967 | +838.9% | 0.02% | +850.0% |
Q3 2022 | $1,553,000 | +748.6% | 86,589 | +354.2% | 0.00% | – |
Q2 2022 | $183,000 | -97.1% | 19,063 | -94.9% | 0.00% | -100.0% |
Q4 2021 | $6,216,000 | +5400.9% | 371,728 | +2172.9% | 0.01% | – |
Q4 2020 | $113,000 | -33.1% | 16,355 | -45.5% | 0.00% | – |
Q3 2020 | $169,000 | -89.3% | 30,020 | -90.3% | 0.00% | -100.0% |
Q2 2020 | $1,575,000 | -10.1% | 308,802 | -39.3% | 0.00% | -33.3% |
Q1 2020 | $1,751,000 | -68.2% | 509,031 | -20.7% | 0.00% | -50.0% |
Q4 2019 | $5,505,000 | +621.5% | 641,588 | -5.9% | 0.01% | +500.0% |
Q3 2019 | $763,000 | -13.9% | 681,661 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $886,000 | – | 681,661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |